Skip to Content

Join the 'Ear Conditions' group to help and get support from people like you.

Ear Conditions News

How to Prevent Painful Swimmer's Ear

Posted 19 Jun 2016 by Drugs.com

SATURDAY, June 18, 2016 – Swimmer's ear – a common summertime problem among children – is easy to prevent, an expert says. "Swimmer's ear is a bacterial or fungal infection caused by water caught in the ear canal. The tell-tale signs are swelling of the ear canal and some drainage or discharge," said Dr. Nina Shapiro, director of pediatric otolaryngology at Mattel Children's Hospital of the University of California, Los Angeles. Other types of ear infections cause pain inside the ear, but swimmer's ear causes pain when the outside of the ear is touched, Shapiro said in a university news release. Swimmer's ear can be prevented by using the corner of a washcloth or towel to dry ears after swimming. If a hair dryer is available, use the low setting and place the dryer about one foot away from the ear to dry it, Shapiro said. Never use a cotton swab to clean or dry the ear canal because ... Read more

Related support groups: Ear Conditions, Acetic Acid, Otitis Externa, Fem pH, Domeboro Otic, Acute Otitis Externa, Auralgan, Vosol, Benzocaine/Isopropyl Alcohol, Auro-Dri, Swim Ear, Acetic Acid/Aluminum Acetate, Isopropyl Alcohol, Star-Otic, Treagan, BD Butterfly Alcohol Pad, Vasotate, Otic Edge, Acetasol, Klout

FDA Approves Otiprio (ciprofloxacin otic suspension) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery

Posted 11 Dec 2015 by Drugs.com

SAN DIEGO, Dec. 11, 2015 (GLOBE NEWSWIRE) – Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that the U.S. Food and Drug Administration (FDA) has approved Otiprio (ciprofloxacin otic suspension) for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement. Otiprio is a single-dose, physician-administered antibacterial and the first product approved by the FDA for this indication. "The approval of Otiprio, our first product, is a landmark moment in the history of Otonomy, and provides important validation for our proprietary drug delivery technology that combines a thermosensitive gel with drug microparticles to enable single dose treatment by a physician," said David A. Weber, Ph.D., ... Read more

Related support groups: Surgery, Ciprofloxacin, Otitis Media, Ear, Ear Conditions, Tympanostomy Tubes, Otiprio

FDA Medwatch Alert: Unapproved Prescription Ear Drop (Otic) Products: Not FDA Evaluated for Safety, Effectiveness and Quality

Posted 1 Jul 2015 by Drugs.com

ISSUE: FDA announced its intention to take enforcement action against companies that manufacture and/or distribute certain unapproved prescription ear drop products (known as otic products) labeled to relieve ear pain, infection, and inflammation. The unapproved prescription ear drops contain active ingredients such as benzocaine and hydrocortisone, and have not been evaluated by the FDA for safety, effectiveness and quality. The labels on these products do not disclose that they lack FDA approval, and health care professionals may not be aware of their unapproved status. Unapproved prescription otic drug products are frequently given to young children suffering from ear infections and other conditions that cause ear pain and swelling. Patients taking unapproved drugs may be at greater risk because there is no proven safety or effectiveness information. These products may be ... Read more

Related support groups: Otitis Media, Benzocaine, Ear Conditions, Allergen, Otitis Externa, Antipyrine/Benzocaine, A/B Otic, Chronic Otitis Media, Cortane-B, Trioxin, Neotic, Tri-Otic, Benzocaine/Chloroxylenol/Hydrocortisone, Oticaine, Aurogard, Dolotic, Uni-Otic Ear Drops, Auroto, Oto-End, Chloroxylenol/Hydrocortisone/Pramoxine

FDA Takes Action Against Unapproved Prescription Ear Drop Products

Posted 1 Jul 2015 by Drugs.com

July 1, 2015 – The U.S. Food and Drug Administration today announced its intention to take enforcement action against companies that manufacture and/or distribute certain unapproved prescription ear drop products (known as otic products) labeled to relieve ear pain, infection, and inflammation. The unapproved prescription ear drops contain active ingredients such as benzocaine and hydrocortisone, and have not been evaluated by the FDA for safety, effectiveness and quality. The labels on these products do not disclose that they lack FDA approval, and health care professionals may not be aware of their unapproved status. In a federal register notice published today, the agency informed the companies that they must stop manufacturing these unapproved prescription otic products or be subject to enforcement actions, including seizure, injunction and/or criminal proceedings. Today’s action ... Read more

Related support groups: Benzocaine, Ear Conditions, Allergen, Antipyrine/Benzocaine, A/B Otic, Benzocaine/Chloroxylenol/Hydrocortisone, Cortane-B, Tri-Otic, Trioxin, Neotic, Oticaine, MyOxin, Dolotic, Uni-Otic Ear Drops, Auroto, Oto-End, Pinnacaine, Hydro Ear, Zoto-HC Drops, Otomar HC

Ask a Question

Further Information

Related Condition Support Groups

Otitis Media, Hearing Loss, Meniere's Disease, Ear Wax Impaction, Otitis Externa, Auditory Processing Disorder

Related Drug Support Groups

benzocaine, Tri-Otic, Oticaine, Cortane-B, Cortamox, IvDerm, Oticin HC, Aero Otic HC, Pinnacaine, view more... Hydro Ear, Benzotic, Cortic-ND, Oto-End, Pramox-HC, Cyotic, Omedia, Otocain, Americaine Otic, chloroxylenol / hydrocortisone / pramoxine, Otozone, Zoto-HC Drops, Zolene HC, Exotic-HC, Otomar HC, Otirx